Literature DB >> 15922112

Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases.

A C Williams1, D B Ramsden.   

Abstract

Monkeys and man are very closely related genetically. Yet intellectually there are big differences and they suffer from a broad range of different diseases. For example, monkeys do not get Parkinson's or Alzheimer's disease. The former is surprising given that both get parkinsonism from MPTP poisoning and the latter initially less surprising as the cortex predominantly affected in Alzheimer's never developed as fully in the monkey. Man is an omnivore whilst other primates are predominantly herbivores. The one primate who was almost wholly carnivorous was Neanderthal man who became extinct. Red meat has a high content of Nicotinamide, Choline, and methyl donors. The enzyme NNMT converts nicotinamide to N-methyl-nicotinamide using SAM as the methyl donor. It is not present to any degree in herbivores. It has recently been shown to be present in human brain and up regulated in Parkinson's disease. Omnivores presumably need it for nicotinamide homeostasis but the production of N-methyl-nicotinamide will also be beneficial as it will reduce the export of Choline from neurones. Both will aid brain growth and development. However, as N-methyl-nicotinamide resembles MPTP it could cause parkinsonism later in life for man but not monkeys as they would be predicted not to have as much NNMT. Humans with a diet low in Nicotinamide,Choline or methyl donors early in life and low enzyme activity may be prone to Alzheimer's as their brain and therefore its reserves may never have developed as fully. The possession of NNMT plus a diet rich in Nicotinamide, Choline and methyl providers may explain many of the advantages but also the disadvantages of the human condition. One prediction is that a diet rich in these micronutrients whilst young will improve brain development and reduce the risk of Alzheimer's but that a lower dose later in life will reduce the risk of Parkinsonism. A second prediction is that it will become clear that dietary factors including vitamins are signalers and at the head of vital biochemical pathways. A time point will be reached when errors emerge that could not be deleted by evolutionary pressures. Finding and rectifying them will be the key to preventing many common diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922112     DOI: 10.1016/j.mehy.2005.01.042

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  12 in total

1.  Effects of N1-methylnicotinamide on oxidative and glycooxidative stress markers in rats with streptozotocin-induced diabetes mellitus.

Authors:  Zuzana Országhová; Ol'ga Uličná; Anna Liptáková; Ingrid Zitňanová; Jana Muchová; Cezary Watala; Zdeňka Duračková
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

2.  Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine.

Authors:  A Chan; F Tchantchou; V Graves; R Rozen; T B Shea
Journal:  J Nutr Health Aging       Date:  2008-04       Impact factor: 4.075

3.  Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma.

Authors:  Davide Sartini; Andrea Santarelli; Valentina Rossi; Gaia Goteri; Corrado Rubini; Domenico Ciavarella; Lorenzo Lo Muzio; Monica Emanuelli
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

4.  Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra.

Authors:  Adrian C Williams; Lisa J Hill; David B Ramsden
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-21

5.  Increased life span due to calorie restriction in respiratory-deficient yeast.

Authors:  Matt Kaeberlein; Di Hu; Emily O Kerr; Mitsuhiro Tsuchiya; Eric A Westman; Nick Dang; Stanley Fields; Brian K Kennedy
Journal:  PLoS Genet       Date:  2005-11-25       Impact factor: 5.917

6.  Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.

Authors:  Andrzej Fedorowicz; Łukasz Mateuszuk; Grzegorz Kopec; Tomasz Skórka; Barbara Kutryb-Zając; Agnieszka Zakrzewska; Maria Walczak; Andrzej Jakubowski; Magdalena Łomnicka; Ewa Słomińska; Stefan Chlopicki
Journal:  Respir Res       Date:  2016-08-31

Review 7.  Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?

Authors:  Lisa J Hill; Adrian C Williams
Journal:  Int J Tryptophan Res       Date:  2017-05-03

Review 8.  The Influence of Nicotinamide on Health and Disease in the Central Nervous System.

Authors:  Rosemary A Fricker; Emma L Green; Stuart I Jenkins; Síle M Griffin
Journal:  Int J Tryptophan Res       Date:  2018-05-21

Review 9.  The 4 D's of Pellagra and Progress.

Authors:  Adrian C Williams; Lisa J Hill
Journal:  Int J Tryptophan Res       Date:  2020-04-16

10.  Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway.

Authors:  Jun Zhang; Yanzhong Wang; Guiling Li; Haitao Yu; Xinyou Xie
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.